Literature DB >> 10749698

Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps.

L Wang1, X Wang, C G Proud.   

Abstract

Insulin acutely activates protein synthesis in ventricular cardiomyocytes from adult rats. In this study, we have established the methodology for studying the regulation of the signaling pathways and translation factors that may be involved in this response and have examined the effects of acute insulin treatment on them. Insulin rapidly activated the 70-kDa ribosomal S6 kinase (p70 S6k), and this effect was inhibited both by rapamycin and by inhibitors of phosphatidylinositol 3-kinase. The activation of p70 S6k is mediated by a signaling pathway involving the mammalian target of rapamycin (mTOR), which also modulates other translation factors. These include the eukaryotic initiation factor (eIF) 4E binding proteins (4E-BPs) and eukaryotic elongation factor 2 (eEF2). Insulin caused phosphorylation of 4E-BP1 and induced its dissociation from eIF4E, and these effects were also blocked by rapamycin. Concomitant with this, insulin increased the binding of eIF4E to eIF4G. Insulin also activated protein kinase B (PKB), which may lie upstream of p70 S6k and 4E-BP1, with the activation of the different isoforms being in the order alpha>beta>gamma. Insulin also caused inhibition of glycogen synthase kinase 3, which lies downstream of PKB, and of eEF2 kinase. The phosphorylation of eEF2 itself was also decreased by insulin, and this effect and the inactivation of eEF2 kinase were attenuated by rapamycin. The activation of overall protein synthesis by insulin in cardiomyocytes was substantially inhibited by rapamycin (but not by inhibitors of other specific signaling pathways, e.g., mitogen-activated protein kinase), showing that signaling events linked to mTOR play a major role in the control of translation by insulin in this cell type.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749698     DOI: 10.1152/ajpheart.2000.278.4.H1056

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

Review 1.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  IGF-I activates the eIF4F system in cardiac muscle in vivo.

Authors:  Thomas C Vary; Charles H Lang
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways.

Authors:  Chiara Gorrini; Fabrizio Loreni; Valentina Gandin; Leonardo A Sala; Nahum Sonenberg; Pier Carlo Marchisio; Stefano Biffo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-16       Impact factor: 11.205

4.  The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner.

Authors:  Ilona Patursky-Polischuk; Miri Stolovich-Rain; Mirit Hausner-Hanochi; Judith Kasir; Nadine Cybulski; Joseph Avruch; Markus A Rüegg; Michael N Hall; Oded Meyuhas
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

5.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

6.  Mechanical stretch activates mammalian target of rapamycin and AMP-activated protein kinase pathways in skeletal muscle cells.

Authors:  Naoya Nakai; Fuminori Kawano; Ken Nakata
Journal:  Mol Cell Biochem       Date:  2015-05-14       Impact factor: 3.396

7.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

8.  Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.

Authors:  Anita Y M Chan; Vernon W Dolinsky; Carrie-Lynn M Soltys; Benoit Viollet; Shairaz Baksh; Peter E Light; Jason R B Dyck
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

Review 9.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

10.  Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes.

Authors:  Lijun Wang; Mark Rolfe; Christopher G Proud
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.